Elicio Therapeutics, Inc.ELTXNASDAQ
Loading
Operating cash flow minus capital expenditures
Latest
$-36.97M
↓ 79% vs avg
Percentile
P11
Within normal range
Streak
1 yr
Consecutive growthContracting
Average
$-20.71M
Historical baseline
| Period | Value | YoY Change |
|---|---|---|
| TTM | $-36.97M | +0.5% |
| 2024 | $-37.16M | -13.4% |
| 2023 | $-32.76M | -43.5% |
| 2022 | $-22.83M | +6.7% |
| 2021 | $-24.46M | -6.7% |
| 2020 | $-22.93M | +7.7% |
| 2019 | $-24.83M | -209.6% |
| 2018 | $-8.02M | -527.8% |
| 2013 | $1.87M | +84.3% |
| 2012 | $1.02M | - |